Opko Health - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsOpko Health

Opko Health(OPK)

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Hyaluronate sodium

polycystic ovary syndrome

,

ovulation induction

bipolar disorder

non-small-cell lung carcinoma

,

,

,

healthy volunteers/patients

Estrogens conjugated

healthy volunteers/patients

,

primary ovarian insufficiency

,

estrogen replacement therapy

,

postmenopausal osteoporosis

,

premature menopause

,

anxiety disorders

,

,

,

ovarian neoplasms

,

pancreatic neoplasms

,

,

ovarian epithelial carcinoma

,

premature birth

,

triple negative breast neoplasms

,

male breast neoplasms

,

hypersensitivity

,

lymphatic metastasis

,

risk reduction behavior

,

cognitive dysfunction

,

multiple sclerosis

,

,

carcinoma in situ

,

breast carcinoma in situ

,

ductal carcinoma breast

,

intraductal carcinoma noninfiltrating

,

castration-resistant prostatic neoplasms

,

small cell carcinoma

,

,

neuroendocrine carcinoma

,

prehypertension

,

parkinson disease

,

,

prostatic hyperplasia

,

wounds and injuries

,

traumatic brain injuries

,

,

,

hemorrhagic shock

,

,

reperfusion injury

,

,

uterine diseases

,

prediabetic state

,

glucose intolerance

,

brain neoplasms

,

prostatic neoplasms

,

breast neoplasms

,

,

,

,

,

cardiovascular diseases

,

coronary disease

,

myocardial ischemia

,

coronary artery disease

,

atherosclerosis

,

,

,

anorexia nervosa

,

hormone replacement therapy

,

hypercholesterolemia

,

,

diabetes mellitus

,

,

endometrial neoplasms

,

,

,

,

,

atrophic vaginitis

,

,

,

pelvic organ prolapse

,

,

overactive urinary bladder

,

,

endometrial hyperplasia

,

urinary tract infections

,

,

,

communicable diseases

,

arteriosclerosis

,

,

depressive disorder

,

,

systemic lupus erythematosus

,

pelvic floor disorders

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

physiological sexual dysfunction

,

bacterial vaginosis

,

vaginal diseases

,

vaginal discharge

,

male urogenital diseases

,

female urogenital diseases

,

urogenital diseases

,

urinary incontinence

,

,

uterine prolapse

,

,

,

major depressive disorder

,

,

postoperative pain

,

gender dysphoria

,

,

,

Aglatimagene besadenovec

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

breast neoplasms

,

ovarian neoplasms

retinal diseases

,

diabetic retinopathy

,

,

macular degeneration

ulcerative colitis

,

,

Sodium ascorbate

prostatic neoplasms

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

,

Sodium chloride

,

healthy volunteers/patients

,

,

therapeutic equivalency

healthy volunteers/patients

,

type 2 diabetes mellitus

,

diabetes mellitus

Gonadotropin, chorionic

assisted reproductive techniques

,

,

,

,

acquired immunodeficiency syndrome

,

metabolic syndrome

,

body weight changes

,

,

,

,

ovarian hyperstimulation syndrome

,

polycystic ovary syndrome

,

,

,

ovulation induction

,

1

2

3

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use